New Val-HeFT data shows valsartan reduces total heart failure hospitalizations
The Val-HeFT study found that valsartan significantly reduced total heart failure hospitalizations and morbidity, with a 27.5% delay to first hospitalization. Valsartan also attenuated the increase in norepinephrine levels associated with heart failure.